Incyte Secures Japan Approval for Minjuvi in DLBCL Care
WILMINGTON, Del., June 20, 2026 Incyte Biosciences Japan G.K. has announced that Japan’s Ministry of Health, Labour and Welfare...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
WILMINGTON, Del., June 20, 2026 Incyte Biosciences Japan G.K. has announced that Japan’s Ministry of Health, Labour and Welfare...
BASEL, Switzerland, June 18, 2026 Roche announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental...
